Inventor · disambiguated record
Pär Gellerfors
Also filed as: GELLERFORS PAER · GELLERFORS PAR · GELLERFORS PAR LARS · GELLERFORS Pär
10 granted patents·9 pending applications·146 citations·filing 1989–2024
90Inventor score
Files withBIOARCTIC NEUROSCIENCE AB6GELLERFORS PAER3BIOARCTIC AB1BioArctic Neruoscience AB1GELLERFORS MIKAEL PAR1
Top patents by PatentIndex Score
19 records- 0194US8106164B2Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereofGELLERFORS PAER·Filed 2005·Granted Jan 31, 2012·40 cites·9 claims
- 0291US8025878B2Protofibril selective antibodies and the use thereofBIOARCTIC NEUROSCIENCE AB·Filed 2007·Granted Sep 27, 2011·49 cites·25 claims
- 0387US8809506B2Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disordersLANNFELT LARS·Filed 2009·Granted Aug 19, 2014·11 cites·44 claims
- 0485US9315569B2Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disordersBIOARCTIC NEUROSCIENCE AB·Filed 2014·Granted Apr 19, 2016·7 cites·29 claims
- 0582US8404459B2Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereofGELLERFORS PAER·Filed 2011·Granted Mar 26, 2013·5 cites·11 claims
- 0681US7709695B1Transgenic mouse expressing arctic mutation E693GBIOARCTIC NEUROSCIENCE AB·Filed 2005·Granted May 4, 2010·4 cites·19 claims
- 0777US8999936B2Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereofBIOARCTIC NEUROSCIENCE AB·Filed 2013·Granted Apr 7, 2015·2 cites·9 claims
- 0872US9034334B2Protofibril selective antibodies and the use thereofGELLERFORS Pär·Filed 2011·Granted May 19, 2015·5 cites·4 claims
- 0970US2023295283A1N-terminal truncated protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer'sBioArctic Neruoscience AB·Filed 2022·Application pending·0 cites
- 1068US5273966AO-glycosylated IGF-1KABI PHARMACIA AB·Filed 1989·Granted Dec 28, 1993·17 cites·3 claims
- 1168US2020215209A1Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related DisordersBIOARCTIC AB·Filed 2019·Application pending·0 cites
- 1263US2024198071A1Sterile vascular access deviceMPG MEDICAL AB·Filed 2024·Application pending·0 cites
- 1352US2016199522A1Antibodies and Vaccines for Use in Therapeutic and Diagnostic Methods for Alpha-Synuclein-Related DisordersBIOARCTIC NEUROSCIENCE AB·Filed 2016·Application pending·0 cites
- 1451US2003223979A1Therapeutic method for treating patients with acute intermittent porphyria (AIP) and other porphyric diseasesFiled 2003·Application pending·0 cites
- 1550US2010311008A1Oral tongue positioning deviceGELLERFORS MIKAEL PAR·Filed 2009·Application pending·0 cites
- 1650US2015307601A1Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereofBIOARCTIC NEUROSCIENCE AB·Filed 2015·Application pending·0 cites
- 1744US6537777B1Human porphobilinogen deaminase sequencesHEMEBIOTECH AS·Filed 1999·Granted Mar 25, 2003·6 cites·13 claims
- 1844US2007099185A1Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor proteinICOGENEX CORP·Filed 2003·Application pending·0 cites
- 1942US2012100129A1N-Terminal Truncated Protofibrils/Oligomers for Use in Therapeutic and Diagnostic Methods for Alzheimer's Disease and Related DisordersGELLERFORS PAER·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pär Gellerfors files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →